Adenoid cystic carcinoma of the head and neck: A single-center analysis of 105 consecutive cases over a 30-year period
Adenoid cystic carcinoma of the head and neck: A single-center analysis of 105 consecutive cases over a 30-year period
复制标题
DOI:
10.1016/j.oraloncology.2013.05.004
复制
发表时间:
2013-08-01
期刊:
影响因子:
4.8
通讯作者:
Leemans, C. Rene
中科院分区:
文献类型:
--
作者:
van Weert, Stijn;Bloemena, Elisabeth;Leemans, C. Rene
Background: Adenoid cystic carcinoma is a rare salivary gland malignancy with a poor disease free survival due to frequent distant metastases and late local recurrences. Previous single-center reports on outcome mostly encompass small series. In this report a relative large series of 105 cases is analyzed, all treated at the VU University Medical Center, Amsterdam, The Netherlands over a 30-year period in which treatment strategies remained unchanged.Methods: All cases of ACC of the head and neck between 1979 and 2009 at our institution were analyzed through a medical chart review. Recurrence patterns and possible prognostic factors (T-stage, N-status, age, gender, type of salivary gland involved, histological grade, surgical margins, perineural invasion (PNI) and postoperative radiotherapy (RT)) were analyzed.Results: One-hundred and five cases of ACC of the head and neck were identified. Five-, ten-and twenty-year survival rates for overall survival were 68%, 52% and 28%, respectively. T-stage, N-status, surgical margins, histological subtype and age were highly significant predictors for survival. PNI was not a negative prognosticator.Conclusions: T-stage, N-status, surgical margins, histological grade and age are the main predictors of survival-outcome in ACC of the head and neck. Distant metastasis frequently develop, mainly in the first 5 years post treatment. Local recurrences often develop even later on, warranting long term follow up of patients treated for ACC. Grade III ACC should be considered a specific entity within the group of ACC due to its typical aggressive biological behavior and relatively poor outcome, implicating the need for an improved adjuvant treatment. (C) 2013 Published by Elsevier Ltd.